Showing results (1841-1850 of 2,150) with videos related to
Sort By:
Pageof 215
Geriatrics & Gerontology International|February 25, 2022
Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes and heart failure with preserved ejection fraction: The EXCEED randomized controlled multicenter studyHiroshi Akasaka, Ken Sugimoto, Ayumi Shintani, et al.Nature Genetics|October 1, 2003
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activationNobunao Wakabayashi, Ken Itoh, Junko Wakabayashi, et al.Frontiers in Immunology|November 11, 2024
A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent feverSaeko Yamada, Yasuo Nagafuchi, Mamiko Yamada, et al.International Journal of Hematology|July 27, 2006
Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's diseaseNoboru Yamagata, Jyunko Fujio, Risen Hirai, et al.Microbiology (Reading, England)|August 24, 2013
Multiple rRNA operons are essential for efficient cell growth and sporulation as well as outgrowth in Bacillus subtilisKoichi Yano, Tetsuya Wada, Shota Suzuki, et al.Brain Tumor Pathology|June 11, 2013
Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostainingHirofumi Hirano, Hajime Yonezawa, Shunji Yunoue, et al.Communications Biology|May 18, 2024
Endothelial ROBO4 suppresses PTGS2/COX-2 expression and inflammatory diseasesMasato Tanaka, Keisuke Shirakura, Yui Takayama, et al.Plos One|December 22, 2017
2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in miceHirofumi Morihara, Masanori Obana, Shota Tanaka, et al.Anticancer Research|March 28, 2023
A Laparoscopically Treated Case of Peritoneal Dissemination Mimicking Liver Metastases from Distal Cholangiocarcinoma Four Years After the Initial PancreaticoduodenectomyKensuke Yamamura, Toru Beppu, Koichi Kinoshita, et al.Science Advances|August 24, 2022
AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombinationShin-Ichi Tsukumo, Poorani Ganesh Subramani, Noé Seija, et al.Pageof 215